Skip to main content

FDA draft guidance

By Dave Muoio | 04:14 pm | February 26, 2019
Also: Blockchain for clinical trials; Peloton's upcoming IPO.
By Jonah Comstock | 11:20 am | June 18, 2014
The FDA has, at long last, released draft guidance for how pharmaceutical companies should behave on limited-character social media platforms like Twitter and when correcting misinformation on third-party sites.